This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2008 Mar 27;358(13):1362-9.

doi: 10.1056/NEJMct0708272.

Hydroxyurea for the treatment of sickle cell anemia

Affiliations

PMID: 18367739
DOI: 10.1056/NEJMct0708272

Review

Hydroxyurea for the treatment of sickle cell anemia

Orah S Platt. N Engl J Med. 2008.

. 2008 Mar 27;358(13):1362-9.

doi: 10.1056/NEJMct0708272.

Author

Affiliation

¹ Department of Laboratory Medicine, Children's Hospital Boston, MA 02115, USA. orah.platt@childrens.harvard.edu

PMID: 18367739
DOI: 10.1056/NEJMct0708272

No abstract available

PubMed Disclaimer

Comment in

Hydroxyurea for sickle cell anemia.
Naina HV, Harris S. Naina HV, et al. N Engl J Med. 2008 Jul 3;359(1):98; author reply 98-9. doi: 10.1056/NEJMc080902. N Engl J Med. 2008. PMID: 18596283 No abstract available.
Hydroxyurea for sickle cell anemia.
Bachmeyer C, Aractingi S, Lionnet F. Bachmeyer C, et al. N Engl J Med. 2008 Jul 3;359(1):98; author reply 98-9. N Engl J Med. 2008. PMID: 18609755 No abstract available.

Similar articles

Hydroxyurea for sickle cell anemia.
Bachmeyer C, Aractingi S, Lionnet F. Bachmeyer C, et al. N Engl J Med. 2008 Jul 3;359(1):98; author reply 98-9. N Engl J Med. 2008. PMID: 18609755 No abstract available.
Hydroxyurea and new agents for the treatment of sickle cell disease.
Rodgers GP. Rodgers GP. Clin Adv Hematol Oncol. 2004 Nov;2(11):713-5. Clin Adv Hematol Oncol. 2004. PMID: 16163257 No abstract available.
Hydroxyurea in very young children with sickle cell anemia is not a cure-all.
Powars DR. Powars DR. J Pediatr. 2001 Dec;139(6):763-4. doi: 10.1067/mpd.2001.120093. J Pediatr. 2001. PMID: 11743496 No abstract available.
Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.
Charache S. Charache S. Semin Hematol. 1997 Jul;34(3 Suppl 3):15-21. Semin Hematol. 1997. PMID: 9317197 Review.
Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
Anderson N. Anderson N. Pediatr Nurs. 2006 Nov-Dec;32(6):541-3. Pediatr Nurs. 2006. PMID: 17256291 Review.

See all similar articles

Cited by

HBx promotes tumorigenicity through RRM2-mediated autophagy in hepatocellular carcinoma.
Li Y, Wang F, Geng Z, He T, Song Y, Wu J, Wang B. Li Y, et al. Cell Biosci. 2024 Sep 10;14(1):116. doi: 10.1186/s13578-024-01298-2. Cell Biosci. 2024. PMID: 39256879 Free PMC article.
Towards genomic medicine: a tailored next-generation sequencing panel for hydroxyurea pharmacogenomics in Tanzania.
Nkya S, Nzunda C, Saukiwa E, Kaywanga F, Buberwa E, Solomon D, Christopher H, Ngowi D, Johansen J, Urio F, Mgaya J, Karim S, Alimohamed MZ, Sangeda RZ, Chamba C, Chimusa ER, Novelli E, Makani J. Nkya S, et al. BMC Med Genomics. 2024 Jul 18;17(1):190. doi: 10.1186/s12920-024-01924-5. BMC Med Genomics. 2024. PMID: 39026269 Free PMC article.
A Pharmacist-Managed Hydroxyurea Prescribing Protocol Improves Uptake and Optimization among Patients with Sickle Cell Disease.
Roessner C, Sale T, Uminski K, Goodyear D, Rydz N. Roessner C, et al. Adv Hematol. 2024 May 30;2024:4753349. doi: 10.1155/2024/4753349. eCollection 2024. Adv Hematol. 2024. PMID: 38912090 Free PMC article.
Computational analysis of anti-cancer drug hydroxyurea adsorption on nanocages of gold, silver and copper: SERS and DFT assessment.
Kumaran S, Vetrivelan V, Muthu S, Al-Saadi AA. Kumaran S, et al. Heliyon. 2024 Jan 10;10(5):e24475. doi: 10.1016/j.heliyon.2024.e24475. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38444468 Free PMC article.
Metabolic regulation of erythrocyte development and disorders.
Lyu J, Ni M, Weiss MJ, Xu J. Lyu J, et al. Exp Hematol. 2024 Mar;131:104153. doi: 10.1016/j.exphem.2024.104153. Epub 2024 Jan 17. Exp Hematol. 2024. PMID: 38237718

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- Genetic Alliance
- MedlinePlus Health Information
Molecular Biology Databases
- Guide to Pharmacology